JD vs ZYME · P/E 7.6, rev $187.20B vs rev $76.3M
JD.com Inc Adr (JD) versus Zymeworks Inc. Common Stock (ZYME) — a side-by-side from cached financials, not a winner call.
JD.com Inc Adr (JD) is a internet retail company listed on US.
Zymeworks Inc. Common Stock (ZYME) is a biotechnology company listed on NASDAQ.
Latest reported JD revenue for 2025-12-31 was $187.20B. Net income was $3.31B. Revenue was up 17.9% from 2024-12-31 to 2025-12-31. JD currently screens at market cap $45.56B and trailing P/E 7.6.
Latest reported ZYME revenue for 2024-12-31 was $76.3M. Net income was -$122.7M. Revenue was up 0.4% from 2023-12-31 to 2024-12-31. ZYME currently screens at market cap $1.68B.
JD currently screens at market cap $45.56B and trailing P/E 7.6. ZYME currently screens at market cap $1.68B.
Not investment advice. Open the JD and ZYME stock pages for the full models.
Not investment advice.